Dae, Precious Arianne F.
HRN: 23-77-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
CEFTRIAXONE 1G (VIAL)
04/09/2025
04/16/2025
IV
500mg
Q12
Partial Thickness Burn 14% TBSA Sec To Scald Burn
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes